SEGMENT REPORTING

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements

SEGMENT REPORTING

	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products			Total
2010:
Total revenue	$	55,655	$	9,796			$	65,451
Operating income (loss)		1,073		(715	)			358
Interest expense		128		61				189
Total assets		53,720		9,328				63,048
Net assets		39,016		6,782				45,798
Capital expenditures		366		254				620
Depreciation and amortization		1,413		885				2,298

	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
2011:
Total revenue	$	57,481	$	12,584		$	70,065
Operating income		1,564		1,685			3,249
Interest expense		107		17			124
Total assets		51,172		10,722			61,894
Net assets		40,435		8,004			48,439
Capital expenditures		495		589			1,084
Depreciation and amortization		1,192		860			2,052

	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
2012:
Total revenue	$	61,502	$	11,303		$	72,805
Operating income		1,160		998			2,158
Interest expense		91		26			117
Total assets		55,071		11,755			66,826
Net assets		39,726		9,136			48,862
Capital expenditures		634		875			1,509
Depreciation and amortization		862		837			1,699

^[1]

[1] Disclosure of reportable segmenys of the company.